Cannabinoids are active compounds found in all three species of Cannabis plants. Those Cannabis strains that are used for fiber and also as a source of CBD are commonly referred to as hemp. Cannabis strains that are used for their THC content as well as for their CBD content are commonly referred to simply as Cannabis. There are dozens of different cannabinoids found in hemp and Cannabis that work together to elicit a healing response within the body. People who experience side effects from THC may find it much easier to use a CBD product that has little or no THC.

While the known list of cannabinoids ranges from 66 to 113, some Cannabis experts claim that, depending upon the classification system being used, there may be as many as 120 cannabinoids  There are many cannabinoids that don’t fit exclusively in one category or another. While most cannabinoids are understood, there are several that have not been sufficiently studied. As research advances, this information will be revealed forming a more thorough understanding of cannabinoids as a whole.

Research on cannabinoids is currently underway to determine potential medical benefits as well as possible side effects. In most cases, the following benefits are found:

  • Anti-inflammatory effects.
  • Relief of both chronic and acute pain.
  • Reduced nausea and vomiting related to chemotherapy treatments for cancer.
  • Antidepressant activity.
  • Dramatic reduction in seizure activity.
  • Reduction in tremors.
  • Improved cognitive function in disorders affecting cognition.
  • Decreased progression of nerve degeneration.
  • Inhibition of certain cancer cells and slowing or halting of tumor growth.
  • Reduced intraocular pressure associated with glaucoma.

To date, very few side effects have been attributed to the use of cannabinoids from hemp or Cannabis and these tend to be minor and either self-resolving or are manageable.

Want to Become a Partner?

Click here to become a distributor or inquire about how UBIX can assist with developing your CBD products.


Cannabidiol (CBD) – Well-known for its ability to control the symptoms of epilepsy and multiple sclerosis, Cannabidiol has few side effects. Most notable are fatigue, diarrhea, and changes in eating habits.

Cannabidiol monomethylether (CBDM) – Proven to treat many symptoms associated with chronic illness, including relief of pain, minimizing inflammation, and reducing anxiety.

Cannabidiolic acid (CBDA) – CBDA is very popular with patients who have epilepsy or suffer from severe nausea caused by cancer treatments. It works quickly and has no psychoactive side effects.

Cannabidiorcol (CBD-C1) – CBD-C1 is beneficial to relieve pain and reduce inflammation, requiring a lower dosage than other CBD counterparts.

Cannabidiorcol (CBD-C4) – CBD-C4 works in much the same way as C1 in terms of relieving pain and general discomfort. Also reduces inflammation.

Cannabidivarin (CBDV) – There is a possibility that CBDV can act as an anti-convulsant, anti-epileptic treatment. Studies are underway to identify how CBDV affects the brain and minimizes seizure activity.

Cannabidivarinic acid (CBDVA) – Has no psychoactive properties and is thought to be an effective anti-inflammatory. Studies are being performed to further identify potential health benefits.

Cannabidivarinic acid (CBDVA-C3) – Works in the same fashion as CBDVA. Also helps to control vomiting, reduce anxiety, and minimize pain. As an anti-emetic, it is effective at countering the side effects of many chemo-related treatments.


Cannabichromene (CBC) – CBC offers many health benefits including antidepressant, pain relief, antiviral, anti-bacterial, anti-fungal, and anti-inflammatory just to name a few.

Cannabichromenic acid (CBCA) – CBCA helps to fight inflammation, minimize discomfort and has strong antibacterial properties that help to fight infection.

Cannabichromevarin (CBCV) – Works well with patients who suffer from major depression, arthritis, chronic pain, and Crohn’s disease.

Cannabichromevarinic acid (CBCVA) – CBCVA does not offer any psychoactive effects on the brain but does help to relieve pain. It also has antidepressant properties, antifungal properties, and antibacterial properties. Shows promise in treating both acne and diarrhea.


Cannabicyclol (CBL) – Has the lowest biological activity of all CBD compounds that have been tested. Very little is known about its properties other than it may inhibit the production of prostaglandins.

Cannabicyclolic acid (CBLA) – Possibly antitumor and anti-inflammatory. Tests are still being performed to identify potential health benefits, especially where cancer and tumor growth is concerned.

Cannabicyclovarin (CBLV) – Known to increase appetite, reduce nausea, relieve pain, and calm anxiety. Works well as part of a cancer treatment plan without causing unpleasant side effects.


Cannabielsoic acid B (CBEA-B) – CBEA-B has shown promise in alleviating symptoms associated with depression, social anxiety, multiple sclerosis, epilepsy, and post-traumatic stress disorder.

Cannabielson (CBE) – Doesn’t cause euphoria, but will minimize depressive behavior, reduces pain, and relieves anxiety.

Cannabielsoin acid A (CBEA-A) – CBEA-A is still being researched, properties are unknown at this time.

Want to Become a Partner?

Click here to become a distributor or inquire about how UBIX can assist with developing your CBD products.


Cannabigerol (CBG) – Currently being tested to determine if it offers benefits for cancer, neurodegeneration and a variety of other health conditions. Properties are unknown at this time.

Cannabigerol monomethlylether (CBGM) – CBGM has shown promise in relieving the symptoms of glaucoma, Crohn’s disease, chronic pain, cancer, and arthritis. It is known to possess anti-inflammatory properties as well as being effective at relieving pain and general discomfort.

Cannabigerolic acid (CBGA) – CBGA possibly relieves intraocular pressure associated with glaucoma and macular degeneration, helps to maintain homeostasis, slows down possible nerve degeneration.

Cannabigerolic acid monomethylether (CBGAM) – Has been proven to provide relief for patients with both irritable bowel syndrome and glaucoma. Also shows promise in reducing the effects of depression as well as inhibiting tumor growth.

Cannabigerovarin (CBGV) – Tests have shown that CBGV can possibly reduce or even halt the growth of leukemia and other cancer cells when used in conjunction with other cannibinoids.

Cannabigerovarinic acid (CBGVA) – CBGVA slows down the rate of nerve degeneration and reduces the inflammation that accompanies irritable bowel disease. May also reduce the growth of cancer tumors.


Cannabinodiol (CBND) – Properties are unknown at this time. Research is still underway to determine any potential health benefits.

Cannabinodivarin (CBVD) – Minimizes nerve excitability and reduces the severity of epileptic seizures and other types of convulsions. May also be beneficial for patients with autism and Rett Syndrome.

Cannabinol (CBN) – CBN has no known psychoactive properties. Potential health benefits are still being researched.

Cannabinol Methylether (CBNM) – Promotes the growth of healthy bone cells, anti-bacterial, anti-inflammatory, anti-insomnia, and proven pain reliever.

Cannabinol-C2 (CBN-C2) – Properties still being researched.

Cannabinol-C4 (CBN-C4) – Properties still being researched.

Cannabinolic acid (CBNA) – Shows anti-inflammatory properties and may possibly be able to relieve insomnia.

Cannabiorcool (CBN-C1) – Testing has not been performed at this time.

Cannabivarin (CBV) – Studies show possible benefits in treating symptoms associated with neuropathic pain, multiple sclerosis, brain tumors, Parkinson’s disease, and Alzheimer’s. May be beneficial in treating psychiatric disorders as well.


10-Ethoxy-9-hydroxy-delta-6a-tetrahydrocannabinol – No medicinal properties are known at this time but research continues.

8,9-Dihyroxy-delta-6a-tetrahydrocannabinol – No medicinal properties are known at this time.

Cannabitriol (CBT) – Studies have yet to be performed as CBT was only reported in 2014. No properties are known at this time but research is underway to uncover any potential health benefits.

Cannabitriolvarin (CBTV) – Studies are still being performed at this time, but it is possible that CBTV may be useful in the treatment of epilepsy. Tests have been performed that indicate that CBTV may have potential to help control seizure activity in the brain.


Delta-8-tetrahydrocannabinols – No medicinal properties are known at this time. Studies are underway to identify any potential benefits.

Delta-8-tetrahydrocannabinol – Anti-nausea and analgesic properties are well known. Also stimulates appetite and protects nerve tissues.

Delta-8-tetrahydrocannabinolic acid – No medicinal properties have been reported at this time, but research is ongoing.

Want to Become a Partner?

Click here to become a distributor or inquire about how UBIX can assist with developing your CBD products.


Delta-9-tetrahydrocannabinol (THC) – Causes distinct euphoria (the high), but also has anti-inflammatory, antioxidant, analgesic, and anti-emetic properties.

Delta-9-tetrahydrocannabinol-C4 (THC-C4) – No medicinal properties are known at this time.

Delta-9-tetrahydrocannabinolic acid A (THC-A) – No medicinal properties are known at this time, but studies are ongoing.

Delta-9-tetrahydrocannabinolic acid B (THC-B) – No medicinal benefits have been reported at this time.

Delta-9-tetrahydrocannabinolic acid-C4 (THCA-C4) – Studies are underway but no medicinal benefits are known at this time.

Delta-9-tetrahydrocannabiorcol (THC-C1) – THC-C1 is still being studied at this time. Possible antinociceptive properties.

Delta-9-tetrahydrocannabiorcolic acid (THCA-C1) – Although studies are underway, no medicinal benefits have been reported at this time.

Delta-9-tetrahydrocannabivarin (THCV) – Shows possible benefits as a bone stimulant, anti-emetic, anti-inflammatory, analgesic, anorectic, anti-epileptic, and anti-emetic. Causes euphoria.

Delta-9-tetrahydrocannabivarinic acid (THCVA) – No medical benefits are known at this time.

10-Oxo-delta-6a-tetrahydrocannabinol (OTHC) – Studies are being performed but at this time there are no known properties.

Cannabichromanon (CBCF) – No known medical properties have been reported at this time.

Cannabifuran (CBF) – Studies are underway, but no benefits have been reported at this time.

Cannabiglendol – No medicinal benefits have been reported at this time, but studies are being performed.

Cannabiripsol (CBR) – Currently being researched. No information is available at this time.

Cannabicitran (CBT) – CBT has the same basic properties as THC, but tests are still being performed to determine if any properties are beneficial.

Dehydocannabifuran (DCBF) – No medicinal properties are known at this time.

Delta-9-cis-tetrahydrocannabinol (cis-THC) – No medicinal properties are known at this time.

Tryhydroxy-delta-9-tetrahydrocannabinol (triOH-THC) – No properties are known at this time.

Ethoxy-cannabitriolvarin (CBTVE) – No medicinal properties are known at this time.

3,4,5,6-Tetrahydro-7-hydroxy-alpha-alpha-2-trimethyl-9-n-propyl-2,6-methano-2H-1-benzoxocin-5-methanol (OH-iso-HHCV) – Has no psychoactive properties. Medicinal properties are unknown.

Want to Become a Partner?

Click here to become a distributor or inquire about how UBIX can assist with developing your CBD products.


HU-210 – prevents inflammation and may slow the progression of Alzheimer’s.

WIN 55,212-2 – Potent analgesic properties, reduces inflammation and reduces neurotoxicity.

JWH-133 – Known to prevent both inflammation and cognitive impairment.

Parahexyl – Synthetic compound that is similar to THC and is currently undergoing testing, but no medicinal properties are listed.

Nabilone – Synthetic cannabinoid compound with proven analgesic effects when used to relieve neurological pain. Also used as an anti-emetic and pain reliever for chemo-induced symptoms.

No THC Oil

NDT (Non-Detectable THC) – This is most of the oil we are seeing out in the market that has no THC but none of the other Cannabinoids. This is what Folium calls PCR.

PCR (Photo cannabinoid-rich oil) – is a NDT oil that has all of the other primary Cannabinoids over 1% CBD, THCV CBG.